• Press Releases
  • SENO Medical Instruments Receives SATAI Award For Opto-Acoustic Cancer Imaging Technology

Newsroom | Press Releases

SENO Medical Instruments Receives SATAI Award For Opto-Acoustic Cancer Imaging Technology

SAN ANTONIO, TEXAS — April 8, 2008 – Seno Medical Instruments, Inc., a San Antonio company engaged in the development of opto-acoustics, the next generation cancer imaging technology, received the prestigious Super Star Award from the San Antonio Technology Accelerator Initiative (SATAI) in recognition for their entrepreneurial development of cutting edge technology in the region.

The award was presented Friday night, April 4, during The SATAI STARs of Innovation banquet at the Skyroom at the International Conference Center at the University of the Incarnate Word in San Antonio.

“This award has great meaning to our company,” said Janet Campbell, CEO of SENO. “To realize SATAI has previously bestowed this award upon such successful companies as KCI and Rackspace, companies that have offered the most innovative and promising technology in our region, makes it even more special. We are proud to be included as members of this select group. Our opto-acoustic imaging technology has the capability to become the new standard for the industry in cancer detection and diagnoses. Opto-acoustics provides high-resolution and high-contrast in real-time, uniquely offering the only blood map in the world for the detection of cancer. I am deeply honored to accept this award tonight and thank SATAI for this recognition.”

The award is part of an annual program developed by the SATAI, a non-profit organization that inspires, creates, and helps grow new technology companies. Each year, the non-profit technology incubator produces a banquet to recognize and showcase leaders in the rapidly growing technology sector in the San Antonio region.

More Seno Press Releases

Seno Medical® Receives Innovative Technology Contract from Vizient For its Imagio® Breast Imaging System
Contract awarded for products that bring improvement to healthcare industry [SAN ANTONIO, TX – November...
Real World Use of OA Imaging Confirms Clinical Acceptability of Second Generation Imagio® Breast Imaging System
[SAN ANTONIO, TX – October 31, 2024] A study published in Academic Radiology, Exploring the Utility of...
IHE SHARAZONE Hits Major Milestone with 15 Participants, Empowering 37 Creators and 24 Consumers
[May 17, 2024] IHE-Europe is thrilled to report a major milestone for the IHE SHARAZONE, a groundbreaking...
American Medical Association Issues New CPT Code for Use of Seno Medical’s Opto-acoustic Technology in Breast Cancer Diagnosis
CPT Code 0857T Enables a Pathway for Reimbursement When Using Seno’s Imagio® Breast Imaging System to Diagnose...
Seno Medical Earns Frost & Sullivan's 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis with Its Cutting-edge Technology
Seno Medical offers highly differentiated opto-acoustic/ultrasound (OA/US) exam to diagnose breast cancer...